Quality of antiepileptic drugs in Vietnam

Epilepsy Research

Volumn 80, Issue 1, 2008, Pages 77-82

  Mac, Tu Luong ^a   Gaulier, Jean Michel ^b   Le, Van Tuan ^c   Vu, Anh Nhi ^c   Preux, Pierre Marie ^a   Ratsimbazafy, Voa ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c Department of Neurology   (Viet Nam)

Author keywords

Anti epileptic drugs; Carbamazepin; Epilepsy; Phenytoin; Quality; Vietnam

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID; ZEP;

ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG INFORMATION; DRUG PACKAGING; DRUG QUALITY; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; LIGHT; PHARMACY; PRIORITY JOURNAL; STORAGE; VIET NAM;

ANTICONVULSANTS; COMMUNITY PHARMACY SERVICES; EPILEPSY; HUMANS; OBSERVATION; PHARMACIES; QUALITY CONTROL; RETROSPECTIVE STUDIES; SAMPLING STUDIES; TECHNOLOGY, PHARMACEUTICAL; VIETNAM;

EID: 46549084578     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.03.006     Document Type: Article

References (22)

1. Anonymous, 1999. Antiepileptics. In: Martindale, The Complete Drug Reference, 32nd ed. Pharmaceutical Press, London, UK, p. 339, 350, 352.
2. Ballereau F., Prazuck T., Schrive I., Lafleuriel M.T., Rozec D., Fisch A., and Lafaix C. Stability of essential drugs in the field: results of a study conducted over a two-year period in Burkina Faso. Am. J. Trop. Med. Hyg. 57 (1997) 31-36
3. Farnarier G., Nimaga K., Desplats D., and Doumbo O. Traitement des épileptiques en milieu rural au Mali. Rev. Neurol. (2002) 158
4. Laroche M.L., Traore H., Merle L., Gaulier J.M., Viana M., and Preux P.M. Quality of phenobarbital solid-dosage forms in the urban community of Nouakchott (Mauritania). Epilepsia 46 (2005) 1293-1296
5. Lillian L., Chun-Hing Y., Der-Jen Y., Mei-Huei C., and Ming-Fang L. Medication education for patients with epilepsy in Taiwan. Seizure 12 (2003) 473-477
6. Mac T.L., Le V.T., Vu A.N., Preux P.M., and Ratsimbazafy V. AEDs availability and professional practices in delivery outlets in a city centre in southern Vietnam. Epilepsia 47 (2006) 330-334
7. Mac T.L., Tran D.S., Quet F., Odermatt P., Preux P.M., and Chong T.T. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet. Neurol. 6 (2007) 533-543
8. Ministère de l'économie, 2005. des finances et de l'industrie, Direction générale du trésor et de la politique économique Les publications des missions économiques, Statistiques économiques, Vietnam, Mai 2005 [Article online]. Available from http://www.missioneco.org/vietnam/documents_new.asp?V=1_PDF_105420 (accessed February 17, 2006).
9. Mori P. Combattre l'épilepsie au Vietnam. Pulsations 4 (2003) 10
10. Newton P., Proux S., Green M., et al. Fake artesunate in Southeast Asia. Lancet 357 (2001) 1948-1950
11. Newton P.N., Dondorp A., Green M., Mayxay M., and White N.J. Counterfeit artesunate antimalarials in Southeast Asia. Lancet 362 (2003) 169
12. Odermatt P., Ly S., Simmala C., Angerth T., Phongsamouth V., Mac T.L., Ratsimbazafy V., Gaulier J.M., Strobel M., and Preux P.M. Availability and costs of antiepileptic drugs and quality of Phenobarbital in Vientiane municipality, Lao PDR. Neuroepidemiology 28 3 (2007) 169-174
13. Organisation Mondiale de la Santé, 2003. Médicaments de qualité inférieure et contrefaits. Available from http://www.who.int/mediacentre/factsheets/fs275/fr/ (accessed September 26, 2005).
14. Petralanda I. Quality of antimalarial drugs and resistance to Plasmodium vivax in Amazonian region. Lancet 346 (1995) 122
15. Pincock S. WHO tries to tackle problem of counterfeit medicines in Asia. BMJ 327 (2003) 1126
16. Reynolds E.H. ILAE/IBE/WHO global campaign "out of the shadows": global and regional developments. Epilepsia 42 (2001) 1094-1100
17. Risha P.G., Vervaet C., Vergote G., Bortel L.V., and Remon J.P. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. Eur. J. Clin. Pharmacol. 59 (2003) 135-141
18. Shakoor O., Taylor R.B., and Behrens R.H. Assessment of the incidence of substandard drugs in developing countries. Trop. Med. Int. Health 2 (1997) 839-845
19. Simonet D. Une analyse du marché pharmaceutique vietnamien. Cahiers santé 11 (2001) 155-160
20. Taylor R.B., Shakoor O., Behrens R.H., Everard M., Low A.S., Wangboonskul J., Reid R.G., and Kolawole J.A. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357 (2001) 1933-1936
21. Wang J.T., Shiu G.K., Ong-Chen T., Viswanathan C.T., and Skelly J.P. Effects of humidity and temperature on in vitro dissolution of carbamazepine tablets. J. Pharm. Sci. 82 (1993) 1002-1005
22. Yang D., Plianbangchang P., Visavarungroj N., and Rujivipat S. Quality of pharmaceutical items available from drugstores in Phnom Penh, Cambodia. Southeast Asian J. Trop. Med. Public Health 35 (2004) 741-747